AlphaCrest Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-21,597
| Closed | -$2.9M | – | 6 |
|
2022
Q3 | $2.9M | Sell |
21,597
-5,453
| -20% | -$732K | 0.18% | 107 |
|
2022
Q2 | $4.14M | Buy |
27,050
+17,729
| +190% | +$2.72M | 0.2% | 97 |
|
2022
Q1 | $1.51M | Sell |
9,321
-10,716
| -53% | -$1.74M | 0.08% | 357 |
|
2021
Q4 | $2.71M | Sell |
20,037
-4,606
| -19% | -$624K | 0.1% | 273 |
|
2021
Q3 | $2.66M | Sell |
24,643
-111,978
| -82% | -$12.1M | 0.14% | 187 |
|
2021
Q2 | $15.4M | Buy |
136,621
+92,563
| +210% | +$10.4M | 0.66% | 3 |
|
2021
Q1 | $4.77M | Buy |
44,058
+32,545
| +283% | +$3.52M | 0.27% | 72 |
|
2020
Q4 | $1.23M | Sell |
11,513
-68,450
| -86% | -$7.34M | 0.1% | 250 |
|
2020
Q3 | $7M | Buy |
79,963
+76,951
| +2,555% | +$6.74M | 0.76% | 4 |
|
2020
Q2 | $296K | Sell |
3,012
-27,116
| -90% | -$2.66M | 0.05% | 637 |
|
2020
Q1 | $2.3M | Buy |
30,128
+12,455
| +70% | +$949K | 0.28% | 47 |
|
2019
Q4 | $1.57M | Buy |
17,673
+12,773
| +261% | +$1.13M | 0.13% | 173 |
|
2019
Q3 | $371K | Sell |
4,900
-42,027
| -90% | -$3.18M | 0.02% | 1041 |
|
2019
Q2 | $3.41M | Buy |
46,927
+33,779
| +257% | +$2.46M | 0.3% | 46 |
|
2019
Q1 | $1.06M | Buy |
+13,148
| New | +$1.06M | 0.16% | 159 |
|